Wolfe, C. Tomashek, K. et. al. ACTT Study group (includes Svec, D.). Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. Lancet Respiratory Medicine. 9/2022; 10(9):888-899. doi: PMID: 35617986. Lancet Respiratory Medicine Wolfe, C. 2022